The global Paclitaxel injection market has witnessed significant growth in the last few years owing to the rising prevalence of different types of cancers including breast cancer, ovarian cancer, lung cancer and others. Paclitaxel injection, also known as Taxol, is derived from the bark of Pacific yew trees. It works by stopping cell proliferation and division through the inhibition of microtubule function during cell division. Paclitaxel injection is commonly used in the chemotherapy treatment of breast, lung, ovarian and certain other cancers.
The global Paclitaxel injection market is estimated to be valued at US$ 6.34 BN in 2024 and is expected to exhibit a CAGR of 12% over the forecast period 2024 to 2031.
Key Takeaways
Key players operating in the global Paclitaxel injection are Bristol-Myers Squibb Company, U & V Cancure Private Limited, Pfizer Inc., Luye Pharma Group, Fresenius Kabi AG , Accord Healthcare , Viatris Inc. , Teva Pharmaceutical Industries Ltd., Dr. Reddy’s Laboratories Ltd. , Sandoz Group AG, Salvavidas, Sun Pharmaceutical Industries Ltd. , Cipla Inc. , Alvogen , Apotex Inc., Bharat Parenterals Limited. These players are actively focused on strengthening their distribution network and innovating newer formulations to expand their market share.
The rising investment in oncology research as well as growing public awareness about cancers have resulted in key opportunities in the market. Additionally, the increasing focus of manufacturers towards emerging markets in Asia Pacific and Latin America will drive the market expansion globally over the forecast period.
Market drivers - Increasing prevalence of different cancer types across the globe is a major market driver. According to WHO, cancer burden has risen to 19.3 million cases and 10 million cancer deaths in 2020. This rising disease burden signifies the need for effective treatment options like paclitaxel injection drugs.
Market restraints - Stringent regulatory landscape pertaining to approval of oncology drugs acts as a major restraint. Extensive clinical trials are required to demonstrate efficacy and safety of oncology therapies which incurs high costs for manufacturers. Additionally, adverse effects associated with chemotherapy also restricts market growth.
Segment Analysis
The Global Paclitaxel Injection Market Size is dominated by breast cancer sub-segment owing to high prevalence and incidence rates of breast cancer globally. Breast cancer accounts for one-fourth of all new cancer cases globally and is the most common cancer worldwide. As per WHO, breast cancer caused 6,85,000 deaths globally in 2020. Paclitaxel injection plays an important role in treating breast cancer and forms a key regimen like AC followed by Paclitaxel. The treatment has resulted in higher survival rates and thus drives the demand for Paclitaxel injection in breast cancer segment. The lung cancer segment is expected to witness fastest growth in the forecast period driven by increasing pollution and high smoking rates globally.
Global Analysis
North America dominates the global paclitaxel injection market due to developed healthcare infrastructure, higher adoption of novel cancer drugs and large clinical trials. The region accounted for over 40% market share in 2024. Asia Pacific region is expected to witness highest growth during the forecast period supported by expanding pharmaceutical industry, increasing cancer awareness and rising healthcare expenditure. Countries like China and India are identified as lucrative markets as they report high cancer incidence. Factors such as rising geriatric population, changing lifestyle and improved access to diagnosis and treatment contribute to the fastest growth of the APAC region in the global paclitaxel injection market.
Get more insights on This Topic- Global Paclitaxel Injection Market
22th October, 2018 – Global Paclitaxel Market analysis includes market development history, product and technology developments, competitive landscape analysis, key countries development status, market development trend, and market comparison analysis.
Paclitaxel belongs to the group of medications called antineoplastic and is widely used in the treatment of cancers.
However, opposing drug reactions related to the drug along with the advent of targeted treatment, new anti-cancer drugs, and personalized medications are expected to be few of the major which might hinder the growth of the overall market over the next few years.Request a Sample Copy of This Report @ https://www.millioninsights.com/industry-reports/paclitaxel-market/request-sampleThe opportunities for the global paclitaxel market lies in its potential to be used for the ailment of several types of cancer.
According to the WHO, breast cancer accounted for approximately 5,21,000 deaths whereas stomach cancer accounted for approximately 7,23,000 deaths alone in the year 2012.
It is also expected that the global paclitaxel market has a high threat of substitutes and extensive research and development is being carried out in anti-cancer drugs.The key market players in the global paclitaxel industry are investing heavily in the research & development activities.
These players are introducing new innovative strategies for marketing as well as new product developments.
Injection Bottle Market Report presents the conceptual study and strategic analysis which provides market scope, applications, a topographical presence that drive the Injection Bottle market.
Injection Bottle Market Global Industry report provides the latest market statistics, industry growth, size, share, trends, as well as driving factors.
The detailed overview of the market segments, product description, Injection Bottle applications is presented in this report.
The injection bottles are the most efficient manner for the transportation of medicines and drugs, the effective parameters of injected drug and relief it brings to the sufferer is driving the market growth.
This study also analyzes the market status, future trends, revenue generation, market share, growth rate, opportunities and challenges, sales volume, market drivers, market restraints, risks, and entry barriers.
The Injection Bottle Market report facilitates businesses to successfully make decisions about business strategies to achieve maximum return on investment (ROI).
"Trending News:Neuralgia Treatment Market Report is Booming Globally by Top Leading Players"The global neuralgia treatment market size is predicted to reach USD 2.83 billion by 2027 according to a new study by Polaris Market Research.
The report “Neuralgia Treatment Market Size, Share & Trends Analysis Report, By Treatment (Drug Based [Anticonvulsant Medicines, Tricyclic Antidepressants], Surgeries [Balloon Compression, Glycerol Injection, Radiofrequency Thermal Lesioning, Stereotactic Radiosurgery, Microvascular Decompression]); By End-Use; By Region, And Segment Forecasts, 2020 – 2027” gives a detailed insight into current market dynamics and provides analysis on future market growth.
The neuralgia treatment market is expected to witness significant growth owing to the increasing incidences of diabetes and trigeminal neuralgia.
Multiple sclerosis decreases the body immunity owing to the neurodegenerative condition which affects the myelin sheath that can cause neuralgia.
This is likely to drive market demand over the forecast period.GET SAMPLE PDF:- https://www.polarismarketresearch.com/industry-analysis/neuralgia-treatment-market/request-for-sampleThe potential drug candidates and the expected drug approval is expected to stimulate the global market, with high concentration of pharmaceutical companies engaged in the research & development of novel drugs for neuralgia treatment.
For instance, U.S-based drug manufacturer, Biogen Inc. is developing BIIB074 (Vixotrigine) for the treatment of trigeminal neuralgia and is currently in phase II.
